{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/chimeric-antigen-receptor-t-cell-publication-spotlight-our-top-recent-peer-reviewed#webpage",
"url": "https://www.fortrea.com/insights/chimeric-antigen-receptor-t-cell-publication-spotlight-our-top-recent-peer-reviewed",
"name": "Chimeric antigen receptor T-cell publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing CAR-T drug development",
"description": "This Fortrea info sheet highlights peer-reviewed oncology scientific publications and research contributions from Fortrea oncologists focused on CAR-T cell therapy and emerging immuno-oncology research strategies. The publication features scientific discussions related to CAR-T cell therapy clinical trials, cellular immunotherapy clinical development, precision oncology approaches, and translational oncology research supporting modern cancer therapeutic development. The featured publications discuss advanced cell therapy clinical research, biomarker research, cancer therapeutics, and evolving immuno-oncology clinical development strategy activities within oncology clinical development programs. The publication also highlights scientific publications in CAR-T therapy and collaborative oncology peer-reviewed publications supporting scientific understanding of cellular immunotherapy, precision medicine in CAR-T therapy, and emerging oncology drug development strategy approaches. By contributing to oncology scientific publications and CAR-T oncology research, Fortrea oncology specialists support continued advancement in advanced cell therapy clinical research and immuno-oncology clinical development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Chimeric antigen receptor T-cell publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing CAR-T drug development",
"item": "https://www.fortrea.com/insights/chimeric-antigen-receptor-t-cell-publication-spotlight-our-top-recent-peer-reviewed"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/chimeric-antigen-receptor-t-cell-publication-spotlight-our-top-recent-peer-reviewed#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/chimeric-antigen-receptor-t-cell-publication-spotlight-our-top-recent-peer-reviewed#webpage"
},
"headline": "Chimeric antigen receptor T-cell publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing CAR-T drug development",
"description": "This Fortrea info sheet highlights peer-reviewed oncology scientific publications and research contributions from Fortrea oncologists focused on CAR-T cell therapy and emerging immuno-oncology research strategies. The publication features scientific discussions related to CAR-T cell therapy clinical trials, cellular immunotherapy clinical development, precision oncology approaches, and translational oncology research supporting modern cancer therapeutic development. The featured publications discuss advanced cell therapy clinical research, biomarker research, cancer therapeutics, and evolving immuno-oncology clinical development strategy activities within oncology clinical development programs. The publication also highlights scientific publications in CAR-T therapy and collaborative oncology peer-reviewed publications supporting scientific understanding of cellular immunotherapy, precision medicine in CAR-T therapy, and emerging oncology drug development strategy approaches. By contributing to oncology scientific publications and CAR-T oncology research, Fortrea oncology specialists support continued advancement in advanced cell therapy clinical research and immuno-oncology clinical development.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/car-t-publication-spotlight-fortrea-oncologists-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}